Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (1446)	2/7/2003 4:24:27 AM
From: Robohogs	Read Replies (3) \| Respond to of 3158

J&J is a very good buyer. The owners of CNTO (years ago) would all be retired by now if they had not voted yes. Remicade is a super blockbuster even as Reopro has been "okay". No one ascribed any value to Remicade which is a lot bigger than Embrel, even though no one notices this fact. Weird isn't it. I could have been rich. Oh well. That is the one company where new drugs were developed as thought (unlike SEPR and ELN and MLNM, etc.). This game really is rigged if the small guy gets the losers and the smart money (read big companies) get the winners early in the process. I know nothing about Scios, just reminiscing about my near miss with great wealth. Jon